Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of DDB2 protein | affects expression | 20106945
|
D001151 |
Arsenic |
Arsenic results in decreased expression of DDB2 mRNA | decreases expression | 19945496
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene affects the expression of DDB2 mRNA | affects expression | 20624995
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in increased expression of DDB2 mRNA | increases expression | 20064835 15735009 20106945
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of DDB2 protein | increases expression | 18085531
|
D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in increased expression of DDB2 mRNA | increases expression | 15336504
|
D016572 |
Cyclosporine |
Cyclosporine results in increased expression of DDB2 mRNA | increases expression | 20106945
|
D015084 |
2,4-Dichlorophenoxyacetic Acid |
2,4-Dichlorophenoxyacetic Acid results in increased expression of DDB2 mRNA | increases expression | 15878651
|
C041517 |
dibenzo(a,l)pyrene |
dibenzo(a,l)pyrene results in increased expression of DDB2 mRNA | increases expression | 15735009
|
D005472 |
Fluorouracil |
DDB2 protein affects the susceptibility to Fluorouracil | affects response to substance | 15331170
|
D005472 |
Fluorouracil |
Fluorouracil results in increased expression of DDB2 mRNA | increases expression | 16584549 15331170 17982676
|
D005472 |
Fluorouracil |
TP53 protein promotes the reaction [Fluorouracil results in increased expression of DDB2 mRNA] | increases expression|increases reaction | 17982676
|
C051890 |
irinotecan |
irinotecan metabolite results in increased expression of DDB2 mRNA | increases expression | 15956246
|
C051890 |
irinotecan |
irinotecan results in increased expression of DDB2 mRNA | increases expression | 15956246
|
C015329 |
lycopene |
lycopene results in increased expression of DDB2 mRNA | increases expression | 16886892
|
C406082 |
monomethylarsonous acid |
monomethylarsonous acid results in decreased expression of DDB2 mRNA | decreases expression | 19945496
|
C121565 |
pifithrin |
pifithrin inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of DDB2 mRNA] | decreases reaction|increases expression | 20064835
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of DDB2 mRNA | affects binding|increases activity|increases expression | 19710929
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of DDB2 mRNA | increases expression | 18301758
|
C017947 |
sodium arsenite |
sodium arsenite results in decreased expression of DDB2 mRNA | decreases expression | 12377979
|
D013749 |
Tetrachlorodibenzodioxin |
pifithrin inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of DDB2 mRNA] | decreases reaction|increases expression | 20064835
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.87 | 15322242 14514962 11752688 |
MESH:D058186 |
Acute Kidney Injury |
|
pifithrin |
4.88 | 17670903 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.12 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
4.41 | 20127859 20464547 |
MESH:D000230 |
Adenocarcinoma |
|
Fluorouracil |
4.41 | 17638652 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
2.65 | 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
9.97 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
9.97 | 16835633 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.73 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
Arsenic |
13.90 | 17306315 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
13.90 | 16712894 17306315 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
2,4-Dichlorophenoxyacetic Acid |
5.14 | 16132792 |
MESH:D000740 |
Anemia |
|
Fluorouracil |
8.69 | 17963324 15504547 16511603 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
8.69 | 11748828 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
4.09 | 19183758 |
MESH:D020261 |
Arsenic Poisoning |
|
Arsenic |
2.87 | 16835338 12569548 18414634 16251483 |
MESH:D050197 |
Atherosclerosis |
|
Arsenic |
3.25 | 12928151 19371607 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
8.78 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
8.78 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.82 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.76 | 15746008 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
1.83 | 20146248 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Fluorouracil |
1.83 | 18608205 18357371 15136595 16557594 19217205 16110121 16595493 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.83 | 20435547 |
MESH:D002276 |
Carcinoid Tumor |
|
Fluorouracil |
4.70 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Fluorouracil |
8.19 | 17121937 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
8.19 | 16835633 |
MESH:D002280 |
Carcinoma, Basal Cell |
|
Arsenic |
3.59 | 17687452 15504454 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
6.63 | 12907637 21507988 12619106 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Arsenic |
6.63 | 17306315 16507464 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Fluorouracil |
6.63 | 17045692 17088986 16332177 18930000 16799960 17971768 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
6.63 | 15276417 16507464 17306315 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Fluorouracil |
3.02 | 18695887 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Arsenic |
10.83 | 15504454 17687452 18922899 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
10.83 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Fluorouracil |
10.83 | 16757204 16280240 17066447 18986760 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
10.83 | 18572023 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Arsenic |
4.08 | 18640142 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.37 | 18670907 16120746 18850075 |
MESH:D002318 |
Cardiovascular Diseases |
|
Arsenic |
3.45 | 15738583 17938729 19152805 |
MESH:D002340 |
Carotid Artery Diseases |
|
Arsenic |
4.31 | 18022660 16973168 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
16.09 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
16.09 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
monomethylarsonous acid |
16.09 | 19716837 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
16.09 | 19524636 20056578 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.16 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
7.76 | 19486331 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
7.76 | 19176532 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.10 | 8697196 12621046 16354765 15668235 15340226 |
MESH:D003110 |
Colonic Neoplasms |
|
Fluorouracil |
3.97 | 17018589 15001691 17172411 17725105 17287894 16340194 17016597 16510598 18772588 17169374 |
MESH:D003110 |
Colonic Neoplasms |
|
irinotecan |
3.97 | 17725105 17287894 |
MESH:D015179 |
Colorectal Neoplasms |
|
Fluorouracil |
2.73 | 15289873 20501625 17594712 16524972 17016601 17454858 16282729 18509181 18448328 16303861 17094418 18802399 18288408 16331619 16391804 17695437 18949393 18383874 15148649 17401013 17255274 14970324 |
MESH:D015179 |
Colorectal Neoplasms |
|
irinotecan |
2.73 | 15273666 18259882 16303861 17159606 17454858 18509181 16391804 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.06 | 17141729 14669216 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.25 | 20055451 10048152 15322242 |
MESH:D007644 |
Darier Disease |
|
Fluorouracil |
4.81 | 16733453 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.43 | 18249437 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.67 | 17107852 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
1.54 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.76 | 11462148 |
MESH:D004487 |
Edema |
|
pirinixic acid |
6.55 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
6.55 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.93 | 18230668 16714409 15322242 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.02 | 10568697 9294722 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7.23 | 20426865 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
7.23 | 16530937 |
MESH:D004938 |
Esophageal Neoplasms |
|
Fluorouracil |
7.23 | 16337965 16785472 16481741 15173087 17638652 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.01 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
7.58 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
7.58 | 19236843 20131406 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.47 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
8.53 | 12639820 12168785 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
8.53 | 20067830 |
MESH:D005534 |
Foot Diseases |
|
Arsenic |
5.59 | 6392382 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.70 | 16452187 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.24 | 8708960 |
MESH:D005910 |
Glioma |
|
Fluorouracil |
2.87 | 16145905 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.62 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Fluorouracil |
3.39 | 18337622 15162350 15102660 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
6.45 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
6.45 | 10048152 11294989 |
MESH:D006331 |
Heart Diseases |
|
pifithrin |
4.59 | 14766674 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.54 | 20558911 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.44 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.34 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
8.31 | 19772884 18467677 19176532 16221962 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
8.31 | 16120746 15340226 12621046 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
3.16 | 12676792 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.08 | 16354765 8697196 18606429 15340226 16959395 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.19 | 20558911 |
MESH:D017488 |
Hyperkeratosis, Epidermolytic |
|
Arsenic |
4.46 | 17050553 |
MESH:D006973 |
Hypertension |
|
Arsenic |
8.59 | 16076760 9931084 11953799 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
8.59 | 10903974 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
8.59 | 18670907 18850075 |
MESH:D006987 |
Hypesthesia |
|
Arsenic |
5.59 | 16093927 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
pifithrin |
5.68 | 19475672 |
MESH:D007248 |
Infertility, Male |
|
2,4-Dichlorophenoxyacetic Acid |
7.43 | 12948887 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
7.43 | 15346721 12646999 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
1.86 | 12200463 12878042 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.63 | 16306350 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.34 | 16580747 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.47 | 15604871 |
MESH:D007642 |
Keratosis |
|
Arsenic |
5.01 | 16930632 12749816 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
6.02 | 8314463 18776723 10903974 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
6.02 | 20008137 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
7.40 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Fluorouracil |
7.40 | 16985049 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Arsenic |
3.55 | 17339181 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
2.14 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
2.14 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Arsenic |
2.54 | 11134558 |
MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
21.95 | 2125692 15890375 9163691 18177683 |
MESH:D008113 |
Liver Neoplasms |
|
Arsenic |
21.95 | 16368122 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
21.95 | 20195826 21137059 |
MESH:D008113 |
Liver Neoplasms |
|
Fluorouracil |
21.95 | 17045692 18383874 16603448 15113037 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
21.95 | 15890375 16377806 20007298 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
21.95 | 15276417 16712894 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
21.95 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
5.81 | 8603461 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
5.81 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
3.17 | 19095001 |
MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
8.57 | 14755239 |
MESH:D008175 |
Lung Neoplasms |
|
Arsenic |
8.57 | 17306315 19168569 17976673 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
8.57 | 20869020 20464547 17053015 18816296 18520028 18569708 20135361 6695378 20064080 |
MESH:D008175 |
Lung Neoplasms |
|
Fluorouracil |
8.57 | 15246190 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
8.57 | 17306315 17077188 16712894 15276417 19931552 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
8.57 | 19555203 11884234 |
MESH:D008178 |
Lupus Erythematosus, Cutaneous |
|
Fluorouracil |
4.81 | 15086387 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
2,4-Dichlorophenoxyacetic Acid |
5.15 | 16132792 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
2.03 | 19082730 16487513 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.82 | 16801185 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
8.54 | 16381670 |
MESH:D009062 |
Mouth Neoplasms |
|
Fluorouracil |
8.54 | 18986760 16757204 |
MESH:D052016 |
Mucositis |
|
irinotecan |
5.03 | 17159606 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.52 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.14 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Arsenic |
9.01 | 15371236 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
9.01 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
2.95 | 16411023 |
MESH:D009362 |
Neoplasm Metastasis |
|
irinotecan |
3.17 | 18259882 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
15.77 | 11141357 |
MESH:D009369 |
Neoplasms |
|
Fluorouracil |
15.77 | 18239605 18600527 16928823 |
MESH:D009369 |
Neoplasms |
|
lycopene |
15.77 | 17051425 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
15.77 | 17405874 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
15.77 | 11559025 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
3.68 | 20056578 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.47 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.29 | 19348381 18481113 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.22 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
Arsenic |
7.46 | 16620997 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
7.46 | 12854658 |
MESH:D009447 |
Neuroblastoma |
|
irinotecan |
3.48 | 8761367 |
MESH:D017599 |
Neuroectodermal Tumors |
|
irinotecan |
4.75 | 8761367 |
MESH:D020078 |
Neurogenic Inflammation |
|
Arsenic |
4.38 | 17056641 |
MESH:D020258 |
Neurotoxicity Syndromes |
|
Fluorouracil |
3.44 | 16436463 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.81 | 20558911 |
MESH:D010051 |
Ovarian Neoplasms |
|
Arsenic |
5.03 | 17306315 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
5.03 | 15276417 17306315 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Fluorouracil |
2.66 | 19003803 16929163 15113037 16500647 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.28 | 12520081 |
MESH:D010523 |
Peripheral Nervous System Diseases |
|
Arsenic |
4.19 | 16093927 |
MESH:D016491 |
Peripheral Vascular Diseases |
|
Arsenic |
5.01 | 15371236 6392382 16905509 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.57 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.22 | 12371664 |
MESH:D011248 |
Pregnancy Complications |
|
2,4-Dichlorophenoxyacetic Acid |
5.74 | 2087686 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.21 | 11118676 11399792 11896295 11222880 |
MESH:D011471 |
Prostatic Neoplasms |
|
Arsenic |
1.89 | 16140617 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
1.89 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
Fluorouracil |
1.89 | 19082440 18626508 |
MESH:D011471 |
Prostatic Neoplasms |
|
lycopene |
1.89 | 17337101 15084515 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
1.89 | 16039940 |
MESH:D011507 |
Proteinuria |
|
Arsenic |
4.01 | 21343184 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.23 | 16882103 |
MESH:D012004 |
Rectal Neoplasms |
|
Fluorouracil |
4.01 | 18722050 16160472 18286688 15538739 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.39 | 19058328 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.85 | 18990726 |
MESH:D012871 |
Skin Diseases |
|
Arsenic |
5.39 | 17938729 19834688 17453740 17050553 6392382 15952646 16353154 16702368 16759981 18709164 17548696 |
MESH:D012871 |
Skin Diseases |
|
monomethylarsonous acid |
5.39 | 17431481 |
MESH:D012878 |
Skin Neoplasms |
|
Arsenic |
17.94 | 15504454 17029826 16251483 17976673 17050553 19538983 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
17.94 | 19755658 10029692 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
17.94 | 18572023 19524636 |
MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
17.94 | 8532709 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
17.94 | 16192470 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.80 | 12854658 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
3.44 | 2093021 20155912 |
MESH:D013274 |
Stomach Neoplasms |
|
Fluorouracil |
3.44 | 17522103 16424979 19015929 16951190 17172411 15786421 18567086 18396642 17498489 19084572 |
MESH:D013274 |
Stomach Neoplasms |
|
irinotecan |
3.44 | 15723263 |
MESH:D013345 |
Subarachnoid Hemorrhage |
|
pifithrin |
6.09 | 18364113 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.93 | 12697716 |
MESH:D014062 |
Tongue Neoplasms |
|
Fluorouracil |
3.99 | 16280240 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Arsenic |
12.01 | 19429237 19322015 18640142 11144890 17306315 15987713 17976673 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
12.01 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
monomethylarsonous acid |
12.01 | 20375083 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
12.01 | 16712894 16452187 17306315 11723127 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Fluorouracil |
9.50 | 16803524 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
9.50 | 11813266 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.01 | 1336536 |
MESH:D014652 |
Vascular Diseases |
|
Arsenic |
11.92 | 17056641 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
11.92 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.62 | 12125929 |
MESH:D020301 |
Vasospasm, Intracranial |
|
pifithrin |
5.64 | 18364113 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.28 | 15886252 |
MESH:D014983 |
Xeroderma Pigmentosum |
marker/mechanism |
|
| |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.47 | 17120751 |